Shu Ishida

726 total citations
22 papers, 303 citations indexed

About

Shu Ishida is a scholar working on Molecular Biology, Cognitive Neuroscience and Cancer Research. According to data from OpenAlex, Shu Ishida has authored 22 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cognitive Neuroscience and 5 papers in Cancer Research. Recurrent topics in Shu Ishida's work include Mesenchymal stem cell research (3 papers), Bone Tumor Diagnosis and Treatments (3 papers) and Neuroethics, Human Enhancement, Biomedical Innovations (3 papers). Shu Ishida is often cited by papers focused on Mesenchymal stem cell research (3 papers), Bone Tumor Diagnosis and Treatments (3 papers) and Neuroethics, Human Enhancement, Biomedical Innovations (3 papers). Shu Ishida collaborates with scholars based in Japan, United States and Singapore. Shu Ishida's co-authors include Yasuyoshi Ueki, Tomoyuki Mukai, Teruhito Yoshitaka, Mizuho Kittaka, Ernst Reichenberger, Robert Rottapel, Noriyoshi Mizuno, Yoshitaka Morita, David A. Fox and Keiichiro Nishida and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Bone and Mineral Research.

In The Last Decade

Shu Ishida

21 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Ishida Japan 10 138 85 68 49 48 22 303
Pam Kurimoto United States 7 262 1.9× 67 0.8× 127 1.9× 25 0.5× 27 0.6× 8 410
Matt Weaver United States 8 142 1.0× 209 2.5× 72 1.1× 23 0.5× 45 0.9× 8 438
Yin-Ji Li Japan 9 228 1.7× 46 0.5× 105 1.5× 109 2.2× 34 0.7× 11 411
Wilson Cheuk Wing Chan Hong Kong 7 265 1.9× 105 1.2× 56 0.8× 31 0.6× 71 1.5× 8 473
Genki Kato Japan 4 333 2.4× 80 0.9× 189 2.8× 46 0.9× 86 1.8× 6 468
Vijayalakshmi Shanmugam United States 9 199 1.4× 137 1.6× 48 0.7× 17 0.3× 33 0.7× 12 342
Y. Kuga Japan 7 68 0.5× 193 2.3× 33 0.5× 38 0.8× 12 0.3× 15 344
Zhenhua Yang United States 10 325 2.4× 26 0.3× 57 0.8× 16 0.3× 62 1.3× 12 418
Jung‐Sun Cho South Korea 10 175 1.3× 35 0.4× 65 1.0× 31 0.6× 45 0.9× 21 365
Silke Wemmert Germany 14 198 1.4× 52 0.6× 105 1.5× 44 0.9× 97 2.0× 34 497

Countries citing papers authored by Shu Ishida

Since Specialization
Citations

This map shows the geographic impact of Shu Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Ishida more than expected).

Fields of papers citing papers by Shu Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Ishida. The network helps show where Shu Ishida may publish in the future.

Co-authorship network of co-authors of Shu Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Ishida. A scholar is included among the top collaborators of Shu Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Ishida. Shu Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawai, Tsutomu, et al.. (2025). Regulating stem cell–based embryo model research in Japan. EMBO Reports. 26(7). 1682–1687. 1 indexed citations
2.
Ishida, Shu & Tsutomu Sawai. (2024). Beyond the Personhood: An In-Depth Analysis of Moral Considerations in Human Brain Organoid Research. The American Journal of Bioethics. 24(1). 54–56. 1 indexed citations
3.
Ishida, Shu, et al.. (2024). Evaluating neuroprivacy concerns in human brain organoid research. Trends in biotechnology. 43(3). 491–493. 4 indexed citations
4.
Ishida, Shu. (2024). Welfare Subjectivism, Sophistication, and Procedural Perfectionism. The Journal of Ethics. 29(1). 155–174.
5.
Ishida, Shu, et al.. (2023). Twitter Mining for Detecting Interest Trends on Biodiversity: Messages from Seven Language Communities. Sustainability. 15(17). 12893–12893. 1 indexed citations
6.
Ishida, Shu, et al.. (2023). A comparative review on neuroethical issues in neuroscientific and neuroethical journals. Frontiers in Neuroscience. 17. 1160611–1160611. 1 indexed citations
7.
Iwata, Tomoyuki, Keita Takahashi, Katsuhiro Takeda, et al.. (2022). Regulation of osteogenesis in bone marrow‐derived mesenchymal stem cells via histone deacetylase 1 and 2 co‐cultured with human gingival fibroblasts and periodontal ligament cells. Journal of Periodontal Research. 58(1). 83–96. 8 indexed citations
8.
Iwata, Tomoyuki, Noriyoshi Mizuno, Shu Ishida, et al.. (2021). Functional Regulatory Mechanisms Underlying Bone Marrow Mesenchymal Stem Cell Senescence During Cell Passages. Cell Biochemistry and Biophysics. 79(2). 321–336. 9 indexed citations
9.
Iwata, Tomoyuki, Noriyoshi Mizuno, Mikihito Kajiya, et al.. (2020). Periodontal ligament cells regulate osteogenesis via miR-299-5p in mesenchymal stem cells. Differentiation. 112. 47–57. 14 indexed citations
10.
Iwata, Tomoyuki, Noriyoshi Mizuno, Mikihito Kajiya, et al.. (2020). Regulation of osteogenesis via miR-101-3p in mesenchymal stem cells by human gingival fibroblasts. Journal of Bone and Mineral Metabolism. 38(4). 442–455. 18 indexed citations
11.
Ishida, Shu. (2020). What Makes Discrimination Morally Wrong? A Harm‐Based View Reconsidered. Theoria. 87(2). 483–499. 3 indexed citations
12.
Yoshitaka, Teruhito, Tomoyuki Mukai, Mizuho Kittaka, et al.. (2014). Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism. Cell Reports. 8(6). 1752–1766. 39 indexed citations
13.
Mukai, Tomoyuki, Shu Ishida, Mizuho Kittaka, et al.. (2014). Loss of SH3 Domain–Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor–Driven and Collagen‐Induced Arthritis in Mice. Arthritis & Rheumatology. 67(3). 656–667. 42 indexed citations
14.
Mukai, Tomoyuki, Shu Ishida, Teruhito Yoshitaka, et al.. (2014). SH3BP2 Gain-Of-Function Mutation Exacerbates Inflammation and Bone Loss in a Murine Collagen-Induced Arthritis Model. PLoS ONE. 9(8). e105518–e105518. 20 indexed citations
15.
Yoshitaka, Teruhito, Mizuho Kittaka, Shu Ishida, et al.. (2014). Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice. Bone. 71. 201–209. 7 indexed citations
16.
Mukai, Tomoyuki, Shu Ishida, Teruhito Yoshitaka, et al.. (2014). SH3BP2 Cherubism Mutation Potentiates TNF-α–Induced Osteoclastogenesis via NFATc1 and TNF-α–Mediated Inflammatory Bone Loss. Journal of Bone and Mineral Research. 29(12). 2618–2635. 51 indexed citations
17.
Yoshitaka, Teruhito, Shu Ishida, Tomoyuki Mukai, et al.. (2013). Etanercept Administration to Neonatal SH3BP2 Knock-In Cherubism Mice Prevents TNF-α-Induced Inflammation and Bone Loss. Journal of Bone and Mineral Research. 29(5). 1170–1182. 26 indexed citations
18.
Fujita, Takashi, T Kinukawa, R. Hattori, et al.. (2009). Successful Renal Transplantation for a Patient With Pyoderma Gangrenosum. Transplantation Proceedings. 41(1). 437–440. 6 indexed citations
19.
Nakada, Teruhiro, Shu Ishida, Satoshi Takahashi, et al.. (2006). Therapeutic Outcome of Hyperbaric Oxygen and Basic Fibroblast Growth Factor on Intractable Skin Ulcer in Legs: Preliminary Report. Plastic & Reconstructive Surgery. 117(2). 646–651. 19 indexed citations
20.
Ohsawa, N, Tomotaka Ito, Shu Ishida, et al.. (1998). A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology. 51(2). 586–589. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pam Kurimoto Breakdown of academic impact, for papers by Matt Weaver Breakdown of academic impact, for papers by Yin-Ji Li Breakdown of academic impact, for papers by Wilson Cheuk Wing Chan Breakdown of academic impact, for papers by Genki Kato Breakdown of academic impact, for papers by Vijayalakshmi Shanmugam Breakdown of academic impact, for papers by Y. Kuga Breakdown of academic impact, for papers by Zhenhua Yang Breakdown of academic impact, for papers by Jung‐Sun Cho Breakdown of academic impact, for papers by Silke Wemmert
Rankless by CCL
2026